How Is Cerebral Palsy Treated in Preterm Infants?

Early-onset cerebral palsy in preterm infants—often diagnosed within the first two years of life—requires a multidisciplinary, evidence-based approach grounded in neuroplasticity and developmental principles. Treatment is not curative but aims to maximize functional independence, minimize secondary complications, and support long-term neurodevelopmental outcomes.

First-line interventions include early referral to pediatric physical therapy, occupational therapy, and speech-language pathology. Physical therapy focuses on improving motor control, postural alignment, and mobility through task-specific training, neuromuscular facilitation techniques (e.g., Neuro-Developmental Treatment), and adaptive equipment such as orthotics or gait trainers. Occupational therapy addresses fine motor skills, sensory processing, and activities of daily living, while speech-language pathology supports feeding safety, oral-motor coordination, and communication—particularly critical in preterm infants with coexisting bronchopulmonary dysplasia or gastroesophageal reflux.

Pharmacologic management targets specific comorbidities: botulinum toxin type A injections are used for focal spasticity affecting function or causing pain; oral baclofen or diazepam may be considered for generalized hypertonia, though evidence in very young children remains limited. Intrathecal baclofen is rarely indicated before age 7 and is generally deferred until motor patterns stabilize.

Surgical interventions—including selective dorsal rhizotomy (SDR) and orthopedic procedures like tendon lengthening or osteotomies—are evaluated only after conservative measures plateau and when objective impairments (e.g., fixed contractures, progressive scoliosis, or gait deviations) significantly limit participation or increase injury risk. SDR is typically reserved for children aged 4–10 years with spastic diplegia, preserved cognitive function, and adequate trunk control.

Emerging adjunctive strategies—such as constraint-induced movement therapy, robotic-assisted gait training, and non-invasive brain stimulation—are under active investigation in clinical trials, but none are yet standard of care for infants or toddlers. Family-centered care, caregiver education, and psychosocial support remain integral components across all stages of intervention.